Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes

Kidney International

Volumn 59, Issue 4, 2001, Pages 1390-1396

  Tsujie, M ^a   Isaka, Y ^a   Nakamura, H ^a   Kaneda, Y ^a   Imai, E ^a   Hori, M ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

EBNA 1; Gene therapy; Luciferase; Progressive renal disease; Transfection

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; LIPOSOME; LUCIFERASE; PLASMID DNA; VIRUS DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA REPLICATION ORIGIN; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GLOMERULUS; IMMUNOFLUORESCENCE; MESANGIUM CELL; NONHUMAN; PARAINFLUENZA VIRUS 1; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RENAL ARTERY; TRANSGENE; VIRUS ENVELOPE;

EID: 0035075615     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590041390.x     Document Type: Article

References (32)

1. Strategies of gene transfer to the kidney
2. Gene transfer into the kidney: Promise for unravelling disease mechanisms, limitations for human gene therapy
3. Gene transfer into the rat renal glomerulus via a mesangial cell vector: Site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo
4. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system-first steps towards gene therapy of alport syndrome
5. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney
6. Inhibition of tgf-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis
7. Introduction of plasmid DNA and nuclear protein into cells by using erythrocyte ghosts, liposomes, and Sendai virus
8. Increased expression of DNA cointroduced with nuclear protein in adult rat liver
9. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells
10. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
11. Activating elements in the promoter region of the chicken beta-actin gene
12. Development and characterization of cationic liposomes conjugated with HVJ (Sendal virus): Reciprocal effect of cationic lipid for in vitro in vivo gene transfer
13. Effect of basic nonbasic amino acid substitutions on transport induced by simian virus 40 T-antigen synthetic peptide nuclear transport signals
14. Conditions affecting direct gene transfer into rodent muscle in vivo
15. Evaluation of the bradford method for protein determination in body fluids
16. Transfer of exogenous genes into the kidney
17. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in raji cells into a single DNA domain
18. Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites
19. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication
20. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes
21. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components
22. Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1
23. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection
24. The potential of extrachromosomal replicating vectors for gene therapy
25. Viral latency and transformation: The strategy of Epstein-Barr virus
26. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1
27. Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells
28. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes
29. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation
30. Epstein-Barr virus recombinants from overlapping cosmid fragments
31. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
32. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation